Author's posts
M3-Backed Medlive Gains Another 2.2%; Adds To New China Billionaire Clan’s Fortune
Medlive users include 58% of China’s registered doctors
U.S.-China Business Outlook: What’s Next?
Join seasoned executives for the 3rd U.S.-China Business Forum next week; registration for the online event is free
Reported ByteDance IPO Highlights Appeal Of Hong Kong Bourse’s Own Shares
HKEX has gained 42% in the past year
Memorial Sloan Kettering Opens Center In India Amid Rising Demand For Healthcare In Asia
Expansion adds to other collaboration in region
Bayer Sees A Golden Age For China’s Pharmaceutical Market
New medicines target an aging yet increasingly well-off country
China Regulator Accepts Akeso, Sino Biopharm Application For Cancer Drug
China is one of the world’s largest markets for cancer treatment
Individuals, Not “Fairy Dust,” May Offer Best Hope For U.S.-China Ties — Kevin Rudd
Cancer will kill more people around the world this year than COVID-19
V Star’s Bruce Yu Finds Homegrown Success In China Venture Capital
V Star’s Bruce Yu earlier in his career worked alongside Forbes Midas List members Jenny Lee and Jinxiu Foo.
Cancer Drug Prospects Help Celgene-Backed Antengene Gain In Hong Kong Debut
China’s influence in the global pharmaceutical industry is on the rise
Biortus Gets $15 Mln From Pharmaron-Backed Bayland Capital
The COVID-19 pandemic has put a spotlight on China’s pharmaceutical industry.
